I am a
Home I AM A Search Login

Papers of the Week

2022 Sep 06

Rheumatol Ther

Ustekinumab Is Rapid-Acting and Is an Effective Long-Term Treatment for Patients with Active Psoriatic Arthritis: Real-World Evidence from the Non-interventional SUSTAIN Study.


Wendler J, Damann N, Röcken M, Teicher V, Schuier M, Hamann F, Schwenke H, Sieburg M, Behrens F
Rheumatol Ther. 2022 Sep 06.
PMID: 36066750.


Psoriatic arthritis (PsA) is a chronic, progressive disease that places a significant burden on patients and healthcare systems. The SUSTAIN study collected real-world evidence on long-term effectiveness, impact on quality of life, and safety of ustekinumab treatment for PsA.